IFPMA Facts and Figures Report
Related news and resources
Open letter from the innovative pharmaceutical industry to G20 Ministers in support of the G20 Health Agenda
On 17 April 2025, IFPMA and IPASA submitted an open letter to G20 Ministers in support of the advancement of the G20 Health Agenda.
Read morePharmaceutical industry issues call for collective action to address the rising global burden of chronic disease
Non-communicable diseases (NCDs) including cancer, diabetes, cardiovascular disease, lung disease, mental health, and neurological disorders are responsible for 75% of deaths worldwide. New research demonstrates that investing an additional 1% of GDP in public healthcare spending, where at least 40% is aimed at preventing and treating NCDs, could save close to 5 million lives each...
Read more
Trade and Health Agenda: A Meaningful World Trade Organization Roadmap to Strengthen Global Health
Ahead of the 14th WTO Ministerial Conference (MC14), trade associations representing the pharmaceutical industry provide a perspective on how WTO Members can a roadmap to strengthen global health through meaningful trade policies.
Read more